A controlled trial of rotigotine monotherapy in early Parkinson's disease
about
Interventions for fatigue in Parkinson's diseaseTransdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's diseaseOptimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's diseaseEfficacy of rasagiline in early Parkinson's disease: a meta-analysis of data from the TEMPO and ADAGIO studies.Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease.Nonergot dopamine-receptor agonists for treating Parkinson's disease - a network meta-analysis.Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease.Qigong exercise for the symptoms of Parkinson's disease: a randomized, controlled pilot study.Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).Rotigotine transdermal patch in Parkinson's disease: a systematic review and meta-analysis.Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal function.Novel pharmacological strategies for motor complications in Parkinson's disease.Advances in the delivery of treatments for Parkinson's disease.Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective.Emerging drugs for Parkinson's disease.Rotigotine for the treatment of Parkinson's disease.Drug Insight: new drugs in development for Parkinson's disease.Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome.Transdermal rotigotine: a new non-ergot dopamine agonist for the treatment of Parkinson's disease.Rotigotine transdermal patch in the treatment of Parkinson's disease and restless legs syndrome.Non-Ergot Dopamine Agonists Do Not Increase the Risk of Heart Failure in Parkinson's Disease Patients: A Meta-Analysis of Randomized Controlled TrialsCurrent approaches to the treatment of Parkinson's diseaseRotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER.Role of dopamine agonists in Parkinson's disease: an update.Current status of symptomatic medical therapy in Parkinson's diseaseRotigotine transdermal system: a short review.Minority enrollment in Parkinson's disease clinical trials.Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage.Pharmacokinetics, safety and tolerability of rotigotine transdermal patch in healthy Japanese and Caucasian subjects.Comparison for Efficacy and Tolerability among Ten Drugs for Treatment of Parkinson's Disease: A Network Meta-Analysis.How should we treat a patient with early Parkinson's disease?Rotigotine transdermal patch: a review of its use in the treatment of Parkinson's disease.Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression.Spotlight on rotigotine transdermal patch in Parkinson's disease.Rotigotine transdermal patch for the treatment of Parkinson's Disease.Drug safety evaluation of rotigotine.Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.Effects of rotigotine on Parkinson's disease-related sleep disturbances.Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome.Modern treatment in Parkinson's disease, a personal approach.
P2860
Q24186581-21307636-BAC6-4E45-8138-940AD43763BEQ28266116-89EA86F6-13BA-43D8-923A-9AAF694C6118Q30493158-BE0237D8-3B3F-4F9F-9EBC-3B2C1BF1759CQ31060186-6CFDBDC5-A929-4229-BBD0-A88087CB20A0Q33260250-88B3DBA9-2F90-4124-9AC3-ABEF86F295F2Q33604937-AB9F0AC8-8E2D-4FE3-AB79-7E29E8DD1E35Q34027880-43D719C3-A0B5-44B3-ADD4-30BC4A75EBEDQ34460202-ACA34F16-C546-4344-B329-CF0EC8E4F833Q34771200-A49EF07F-6465-46C0-9CDF-CF8A332D6D2EQ34921068-4799B533-C1D4-42A7-AFDB-CE0388C23023Q35640441-50422FAF-82CC-43DB-A7C2-117E5EC55AF4Q36120761-8722EE18-A247-4987-A46D-3882F3C33174Q36316936-E2232810-220E-41F6-8DFF-37474B7BC8C2Q36382845-1B3B3E46-3721-4B48-B152-911C0FA68017Q36580572-8AD89C18-E1FA-476A-AED5-B7948EA0E9F7Q36607314-5AB9A2C6-4994-46C3-B45E-E158A5226F3BQ36631654-FFDE068D-35DA-44EF-BF15-68B5E9E07854Q36703436-F6B8EFD1-3EF3-416E-B146-2EC39E75A744Q36750148-94AEC63D-A178-4B72-923C-9485389100EBQ36847306-12623ED6-C7E0-4AF9-BBF9-14270D187AC0Q36856977-10BC1E14-49FF-4F61-987B-0B3D4C184B32Q36876438-610F1BB9-4165-4665-BF44-F0D020B6A0FDQ36941752-B616B4FB-9D6D-4438-9B11-0E852EB0F152Q36972701-E6DEF40E-AB55-4F34-B784-D57E9C8F6E1AQ37131229-3997C62F-AC0C-4E86-90C7-D91A84719946Q37166126-5E99863D-AA01-4562-A238-5BA496E375A1Q37236732-BED30F4F-E69A-40AC-B1D4-8D1B276DF0AEQ37382891-8FB78455-E602-4B49-98CA-B7A6F5BDCA80Q37506391-59BEB687-B2E4-4818-94BD-228B78B919EBQ37736512-7DF106D1-51A9-449B-86E9-3F5021F7BD6CQ37775098-15C10DC2-91FC-418B-8B02-C60B1F7F56DBQ37905769-806C9372-74F9-4763-8D9A-EB87FB331BCCQ37924626-974D2532-EBC7-4BE3-8650-00C491E87443Q37960901-5A6BFE25-B83D-4B48-91EE-200200B29CEEQ37982789-B8B6AF63-94DC-40E4-A36F-4A4EE963B2AFQ37999056-703E53C6-043D-4B44-B05E-8989A1C93380Q38070888-8B9AA0AC-4DA3-4A55-A3EC-62A0BD520CFAQ38153751-EB2B68BB-C6C1-48C8-88F5-2BC657C6FF7FQ38242043-45554CE8-0826-4F63-8A59-F21474C9B168Q38570529-D869C35A-ECCB-406E-ACE0-FD3A2F3D51FE
P2860
A controlled trial of rotigotine monotherapy in early Parkinson's disease
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A controlled trial of rotigotine monotherapy in early Parkinson's disease
@ast
A controlled trial of rotigotine monotherapy in early Parkinson's disease
@en
A controlled trial of rotigotine monotherapy in early Parkinson's disease
@nl
type
label
A controlled trial of rotigotine monotherapy in early Parkinson's disease
@ast
A controlled trial of rotigotine monotherapy in early Parkinson's disease
@en
A controlled trial of rotigotine monotherapy in early Parkinson's disease
@nl
prefLabel
A controlled trial of rotigotine monotherapy in early Parkinson's disease
@ast
A controlled trial of rotigotine monotherapy in early Parkinson's disease
@en
A controlled trial of rotigotine monotherapy in early Parkinson's disease
@nl
P3181
P1433
P1476
A controlled trial of rotigotine monotherapy in early Parkinson's disease
@en
P304
P3181
P356
10.1001/ARCHNEUR.60.12.1721
P407
P577
2003-12-01T00:00:00Z